Alps Group Inc (ALPS)
Alps Group Inc is a biotechnology company listed on the NASDAQ under the ticker ALPS. As a common stock security, it represents equity in the company rather than a fund, preferred share, or debt instrument. The company is based in Kuala Lumpur, Malaysia, and its stated business activities include research and development, medical services, and wellness solutions focused on advanced therapies. Alps Group operates within the healthcare sector and biotechnology industry, reflecting its emphasis on science-based and therapeutic-related activities.
Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ
Jump directly to the stock analysis sections supported by the latest available data.
Data update note:
Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Overall Financial Health | Dividend Yield | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-ALPS
|
$0.30
|
-26.0% Downside
|
Overvalued
|
Not available
|
Not available
|
Weak
|
0.0%
|
25.3x
|
17.8x
|
66.56 M
|
59.812 M
|
1.2%
|
29.1%
|
-5.5
|
63.6%
|
